Found 12 matching trials
A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets. PHASE3 The objective of this study is to determine the effect of two dose strength...
Show More Learn More & Join Trial
Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis PHASE3 The purpose of this study is to investigate the safety and efficacy of a lo...
Show More Location
North Central Neurology Associates, PC
Learn More & Join Trial
A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis PHASE3 This is a multicenter study conducted in 3 parts. Part A is a double-blind ...
Show More Learn More & Join Trial
Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials. PHASE3 The primary objective of the study is to evaluate the long-term safety and ...
Show More Location
Foothills Medical Center
Learn More & Join Trial
Effect of Dalfampridine in Patients With Hereditary Spastic Paraplegia NA There are limited but encouraging results supporting the use of dalfampridi...
Show More Location
Dr. Burhan Nalbantoğlu State Hospital
Learn More & Join Trial
Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. PHASE2 The objectives of this study in Multiple Sclerosis (MS) participants treate...
Show More Learn More & Join Trial
Dalfampridine in Egyptian Patients With Multiple Sclerosis NA The only approved treatment for impaired ambulation in MS is Dalfampridine ...
Show More Location
Ain Shams Univeristy
Learn More & Join Trial
Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults PHASE2 In this protocol the investigators will test the effect of dalfampridine (a...
Show More Location
Sleep Disorders Research Program Brigham and Women's Hospital
Learn More & Join Trial
Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord Injury PHASE2 The purpose of this study is to determine the efficacy, safety, and tolerab...
Show More Location
Kessler Institute for Rehabilitation
Learn More & Join Trial
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine. PHASE3 This is an extension study to evaluate the long-term safety, tolerability, ...
Show More Learn More & Join Trial